Finally, to determine whether blocking TGF-β/SMAD signaling could inhibit glycolysis, we quantified the expression of key metabolic enzymes in CRC cells treated with 10 μM LY2157299 for 48 h. Here, TGFB1 is linked to colorectal carcinoma.